CTOs on the Move

Cellenkos Incorporated

www.cellenkosinc.com

 
Cellenkos is an early stage clinical biotechnology company that focuses on cord blood-derived T-regulatory cellular therapies for the treatment of autoimmune diseases and inflammatory conditions. Cellenkos is founded on the technologies arising from the laboratory investigations of Simrit Parmar, M.D. Cellenkos` lead product CK0801 delivers clinically meaningful doses of allogeneic cord blood T-regulatory cells to overcome immune dysfunction.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Elizabeth Read
Chief Technology Officer Profile

Funding

Cellenkos Incorporated raised $15M on 11/04/2021

Similar Companies

Pathology Solutions

Pathology Solutions is a Eatontown, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gallus Biopharmaceuticals

Gallus Biopharmaceuticals is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bioscan, Inc.

Bioscan, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Washington, DC. To find more information about Bioscan, Inc., please visit www.bioscan.com

HealthLogic Systems Corporation

HealthLogic Systems Corporation is a Norcross, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical University of South Carolina Health

The Medical University of South Carolina (MUSC) is a public institution of higher learning the purpose of which is to preserve and optimize human life in South Carolina and beyond. The university provides an interprofessional environment for learning and discovery through education of health care professionals and biomedical scientists, research in the health sciences and provision of comprehensive health care.